UCBJY vs. ZIVO

Last updated Jun 9, 2026

UCBJY (UCB SA ADR) and ZIVO (ZIVO Bioscience, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, UCBJY returned 16.39%/yr vs 23.62%/yr for ZIVO. At a 0.04 correlation, their price movements are largely independent.

Performance

UCBJY vs. ZIVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UCB SA ADR (UCBJY) and ZIVO Bioscience, Inc. (ZIVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UCBJY achieves a 8.13% return, which is significantly higher than ZIVO's -64.94% return. Over the past 10 years, UCBJY has underperformed ZIVO with an annualized return of 16.39%, while ZIVO has yielded a comparatively higher 23.62% annualized return.

UCBJY

• 1D: 0.41%
• 1M: 8.65%
• YTD: 8.13%
• 6M: 4.81%
• 1Y: 63.21%
• 3Y*: 49.75%
• 5Y*: 26.47%
• 10Y*: 16.39%

ZIVO

• 1D: 0.00%
• 1M: -18.67%
• YTD: -64.94%
• 6M: -67.89%
• 1Y: -82.28%
• 3Y*: -42.83%
• 5Y*: -36.44%
• 10Y*: 23.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UCBJY vs. ZIVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UCBJY UCB SA ADR	8.13%	42.69%	129.19%	12.67%	-30.04%	6.90%	34.46%	-1.59%	9.33%	21.37%
ZIVO ZIVO Bioscience, Inc.	-64.94%	-59.53%	1,691.67%	-92.00%	-12.89%	1,813.33%	-11.76%	30.77%	44.44%	-5.26%

Correlation

The correlation between UCBJY and ZIVO is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (5Y) Calculated over the trailing 5-year period	0.05
Correlation (10Y) Calculated over the trailing 10-year period	0.05
Correlation (All Time) Calculated using the full available price history since Sep 25, 2012	0.04

Fundamentals

Market Cap UCBJY : $58.31B ZIVO : $11.85M
EPS UCBJY : $6.73 ZIVO : -$2.58
PS Ratio UCBJY : 4.21 ZIVO : 98.33
Total Revenue (TTM) UCBJY : $13.86B ZIVO : $119.03K
Gross Profit (TTM) UCBJY : $10.00B ZIVO : $39.21K
EBITDA (TTM) UCBJY : $4.56B ZIVO : -$9.86M

Return for Risk

UCBJY vs. ZIVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UCBJY

UCBJY Risk / Return Rank: 84
UCBJY Sharpe Ratio Rank: 87
UCBJY Sortino Ratio Rank: 84
UCBJY Omega Ratio Rank: 85
UCBJY Calmar Ratio Rank: 83
UCBJY Martin Ratio Rank: 83

ZIVO

ZIVO Risk / Return Rank: 17
ZIVO Sharpe Ratio Rank: 22
ZIVO Sortino Ratio Rank: 26
ZIVO Omega Ratio Rank: 26
ZIVO Calmar Ratio Rank: 8
ZIVO Martin Ratio Rank: 4

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UCBJY vs. ZIVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UCB SA ADR (UCBJY) and ZIVO Bioscience, Inc. (ZIVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UCBJY	ZIVO	Difference
Sharpe ratio: Return per unit of total volatility	1.83	-0.47	+2.30
Sortino ratio: Return per unit of downside risk	2.54	-0.23	+2.77
Omega ratio: Gain probability vs. loss probability	1.34	0.97	+0.37
Calmar ratio: Return relative to maximum drawdown	2.92	-0.88	+3.80
Martin ratio: Return relative to average drawdown	7.25	-1.63	+8.88
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UCBJY vs. ZIVO - Sharpe Ratio Comparison

The current UCBJY Sharpe Ratio is 1.83, which is higher than the ZIVO Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of UCBJY and ZIVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	UCBJY	ZIVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.83	-0.47	+2.30
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.88	-0.26	+1.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.54	0.02	+0.52
Sharpe Ratio (All Time) Calculated using the full available price history	0.57	0.01	+0.56

Drawdowns

UCBJY vs. ZIVO - Drawdown Comparison

The maximum UCBJY drawdown since its inception was -50.32%, smaller than the maximum ZIVO drawdown of -98.52%. Use the drawdown chart below to compare losses from any high point for UCBJY and ZIVO.

Drawdown Indicators

	UCBJY	ZIVO	Difference
Max Drawdown Largest peak-to-trough decline	-50.32%	-98.52%	+48.20%
Max Drawdown (1Y) Largest decline over 1 year	-21.77%	-93.85%	+72.08%
Max Drawdown (3Y) Largest decline over 3 years	-28.58%	-97.16%	+68.58%
Max Drawdown (5Y) Largest decline over 5 years	-46.82%	-98.52%	+51.70%
Max Drawdown (10Y) Largest decline over 10 years	-50.32%	-98.52%	+48.20%
Current Drawdown Current decline from peak	-10.15%	-90.67%	+80.52%
Average Drawdown Average peak-to-trough decline	-13.15%	-63.75%	+50.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.75%	50.41%	-41.66%

Volatility

UCBJY vs. ZIVO - Volatility Comparison

The current volatility for UCB SA ADR (UCBJY) is 7.48%, while ZIVO Bioscience, Inc. (ZIVO) has a volatility of 51.45%. This indicates that UCBJY experiences smaller price fluctuations and is considered to be less risky than ZIVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UCBJY	ZIVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.48%	51.45%	-43.97%
Volatility (6M) Calculated over the trailing 6-month period	23.81%	144.20%	-120.39%
Volatility (1Y) Calculated over the trailing 1-year period	34.79%	176.32%	-141.53%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.19%	139.16%	-108.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.62%	1,082.76%	-1,052.14%

Dividends

UCBJY vs. ZIVO - Dividend Comparison

UCBJY's dividend yield for the trailing twelve months is around 0.57%, while ZIVO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
UCBJY UCB SA ADR	0.57%	0.57%	0.73%	1.67%	1.79%	0.86%	0.78%	1.06%	1.10%	2.71%	3.21%
ZIVO ZIVO Bioscience, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both UCBJY and ZIVO in my portfolio?

UCBJY and ZIVO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UCBJY or ZIVO?

ZIVO has higher volatility (51.45%) compared to UCBJY (7.48%). In terms of maximum drawdown, UCBJY dropped -50.32% vs ZIVO's -98.52%.

Which has better risk-adjusted returns?

UCBJY currently has the higher Sharpe Ratio (1.83 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.